"Advanced Liver Therapies at Baylor College of Medicine is a clinical research center dedicated exclusively to the development of new diagnostic tests and therapies for adults with liver diseases."

During the past decade, Baylor College of Medicine - Advanced Liver Therapies conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor College of Medicine - Advanced Liver Therapies" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Conatus Pharmaceuticals Inc." with 3 trials sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored, "Pharmasset" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine - Advanced Liver Therapies" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine - Advanced Liver Therapies" are "Nonalcoholic Steatohepatitis" (5 trials), "Hepatitis C" (3 trials), "Chronic Hepatitis" (2 trials), "Hepatitis B" (2 trials) and "Non-Alcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Baylor College of Medicine - Advanced Liver Therapies" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine - Advanced Liver Therapies" are "Drug" (21 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ribavirin" (3 trials), "SEL" (3 trials), "Adefovir" (2 trials) and "CTS-1027" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine - Advanced Liver Therapies" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Baylor College of Medicine - Advanced Liver Therapies". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Baylor College of Medicine - Advanced Liver Therapies, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine - Advanced Liver Therapies, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".